Ophthalmic Equipment Market - Global Forecast To 2030
商品番号 : SMB-20803
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年11月 |
| ページ数 | 474 |
| 図表数 | 575 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 7,150 |
| 種別 | 英文調査報告書 |
眼科機器市場 – テクノロジー（AI対応機器）、製品タイプ（外科用機器（眼科用顕微鏡）、診断・モニタリング機器（光干渉断層撮影装置、スリットランプ）、エンドユーザー（病院） – 2030年までの世界予測
眼科機器市場は、予測期間中に5.9%のCAGRで成長し、2025年の196億5,000万米ドルから2030年には261億4,000万米ドルに達すると予測されています。
眼科機器市場は、白内障、緑内障、糖尿病網膜症といった眼疾患の増加と世界的な人口高齢化によって牽引されています。OCTや眼底カメラといった高度な診断ツールの利用増加、医療費の増加、そして発展途上国における眼科医療サービスへのアクセス拡大も、市場の成長を牽引しています。さらに、低侵襲性眼科ソリューションやAIを活用した眼科ソリューションを支える技術革新も、その普及を後押ししています。しかしながら、機器価格の高騰と熟練した専門家の不足が市場拡大の制約となっています。
本レポートは、眼科機器市場を評価し、技術、製品タイプ、エンドユーザー、地域など、様々なセグメントにおける市場規模と将来の成長可能性を予測しています。また、主要企業の競合分析も提供しており、企業概要、製品ラインナップ、最近の動向、主要な市場ダイナミクス戦略などを網羅しています。
本レポートは、市場全体、眼科機器セクター、およびそのサブセグメントの概算収益データを提供することで、市場リーダー企業と新規参入企業を支援します。また、ステークホルダーが競争環境を理解し、事業のポジショニングを改善し、効果的な市場開拓戦略を策定するための洞察を得るのに役立ちます。さらに、本レポートは、市場における主要な推進要因、障壁、障害、そして機会に関するデータを提供することで、ステークホルダーが市場の動向を把握するのに役立ちます。
本レポートでは、以下の点について考察します。
主要な推進要因（高齢化人口の増加、眼疾患の有病率の上昇、眼科機器の技術進歩、視力障害対策に向けた政府の取り組みの強化）、制約要因（眼科機器の高コスト、眼科手術に伴う高コストとリスク、再生眼科機器の採用増加）、機会（新興市場における潜在的な成長機会、新興市場における超音波水晶体乳化吸引術デバイスおよびプレミアムIOLの採用率の低さ）、課題（低所得国における眼科医療へのアクセスの低さ、熟練した専門家の不足）の分析
- 製品強化／イノベーション：世界の眼科機器市場における新製品の発売と予想されるトレンドに関する包括的な詳細情報
- 市場開発：技術、製品タイプ、エンドユーザー、地域別に、収益性の高い成長市場に関する徹底的な知識と分析
- 市場多様化：世界の眼科機器市場における新製品、拡大市場、現在の進歩、投資に関する包括的な情報
- 競合評価：世界の眼科機器市場における主要競合他社の市場シェア、成長計画、提供内容、および能力に関する徹底的な評価
Report Description
The ophthalmic equipment market is projected to reach USD 26.14 billion by 2030 from USD 19.65 billion in 2025, at a CAGR of 5.9% during the forecast period.
The ophthalmic equipment market is mainly propelled by the increasing prevalence of eye conditions such as cataracts, glaucoma, and diabetic retinopathy, along with the aging global population. Rising use of advanced diagnostic tools like OCT and fundus cameras, higher healthcare expenditures, and broader access to eye care services in developing countries also drive market growth. Additionally, innovations in technology that support minimally invasive and AI-based eye care solutions boost adoption. However, high equipment costs and a shortage of skilled professionals limit market expansion.
By product type, surgical devices dominate the ophthalmic equipment market because of the high volume of cataract, refractive, and glaucoma surgeries worldwide. Advances in microsurgical techniques, femtosecond lasers, and phacoemulsification systems have improved precision and outcomes, increasing their adoption. Additionally, the growing elderly population and the expanding availability of advanced surgical centers further boost demand for ophthalmic surgical devices.
By end user, hospitals hold the largest share in the ophthalmic equipment market because they serve as primary centers for comprehensive eye care, providing both diagnostic and surgical services. They have advanced infrastructure and skilled ophthalmologists, and they attract more patients than clinics. Additionally, hospitals’ ability to invest in high-end ophthalmic equipment for complex procedures strengthens their dominance in the overall market.
North America holds the largest share of the ophthalmic equipment market because of its advanced healthcare infrastructure, high adoption of innovative diagnostic and surgical technologies, and a strong presence of leading manufacturers. The region benefits from significant healthcare spending, supportive reimbursement policies, and a large number of trained ophthalmologists. Additionally, the increasing prevalence of age-related eye diseases like glaucoma and macular degeneration further boosts equipment demand, while ongoing innovation and early technology adoption help sustain the market dominance.
A breakdown of the primary participants (supply-side) for the ophthalmic equipment market referred to in this report is provided below:
- By Company Type: Tier 1:34%, Tier 2: 38%, and Tier 3: 28%
- By Designation: C-level: 26%, Director Level: 35%, and Others: 39%
- By Region: North America: 17%, Europe: 39%, Asia Pacific: 28%, Latin America: 8%, Middle East & Africa: 3%, GCC Countries: 5%
Prominent players in the ophthalmic equipment market are Bausch Health Companies, Inc. (Canada), Alcon (US), Carl Zeiss Meditec AG (Germany), Johnson & Johnson Vision Care (US), HOYA Corporation (Japan), EssilorLuxottica (France), Canon Inc. (Japan), Glaukos Corporation (US), Nidek Co., Ltd. (Japan), Topcon Corporation (Japan), Staar Surgical (US), Haag-Streit (Switzerland), Visionix (France), Shanghai Mediworks Precision Instruments Co., Ltd. (China), Halma plc (UK), among others.
Research Coverage
The report assesses the ophthalmic equipment market and estimates its size and future growth potential across various segments, including technology, product type, end user, and region. It also provides a competitive analysis of the major players, featuring company profiles, product offerings, recent developments, and key market dynamics strategies.
Reasons to Buy the Report
The report will help market leaders and new entrants by providing data on approximate revenue figures for the overall market, the ophthalmic equipment sector, and its subsegments. It will assist stakeholders in understanding the competitive landscape and gaining insights to better position their businesses and develop effective go-to-market strategies. Additionally, the report helps stakeholders grasp the market pulse by offering data on key drivers, barriers, obstacles, and opportunities in the market.
This report provides insights into the following points:
Analysis of key drivers (Increasing geriatric population, Rising prevalence of eye disorders, Technological advancements in ophthalmic devices, and Increased government initiatives to control visual impairment), restraints (High cost of ophthalmology devices, High cost and risk associated with eye surgeries and Rising adoption of refurbished ophthalmic devices), opportunities (Potential growth opportunities in emerging markets and Low adoption of phacoemulsification devices and premium IOLs in emerging markets), and challenges (Low accessibility to eye care in low-income countries, Lack of skilled professionals)
- Product Enhancement/Innovation: Comprehensive details about product launches and anticipated trends in the global ophthalmic equipment market
- Market Development: Thorough knowledge and analysis of the profitable rising markets by technology, product type, end user, and region
- Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global ophthalmic equipment market
- Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings, and capacities of the major competitors in the global ophthalmic equipment market
Table of Contents
1 INTRODUCTION 38
1.1 STUDY OBJECTIVES 38
1.2 MARKET DEFINITION 38
1.3 STUDY SCOPE 39
1.3.1 SEGMENTS COVERED & REGIONAL SCOPE 39
1.3.2 INCLUSIONS & EXCLUSIONS 40
1.3.3 YEARS CONSIDERED 42
1.4 CURRENCY USED 42
1.5 STAKEHOLDERS 43
1.6 LIMITATIONS 43
1.7 SUMMARY OF CHANGES 43
2 RESEARCH METHODOLOGY 45
2.1 RESEARCH DATA 45
2.1.1 SECONDARY DATA 45
2.1.1.1 Key data from secondary sources 46
2.1.2 PRIMARY DATA 47
2.1.2.1 Key data from primary sources 48
2.1.2.2 Key industry insights 49
2.2 MARKET SIZE ESTIMATION 50
2.2.1 CAGR PROJECTIONS 54
2.2.2 TOP-DOWN APPROACH 55
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 57
2.4 MARKET SHARE ESTIMATION 58
2.5 STUDY ASSUMPTIONS 58
2.6 LIMITATIONS 58
2.6.1 METHODOLOGY-RELATED LIMITATIONS 58
2.7 RISK ASSESSMENT 59
3 EXECUTIVE SUMMARY 60
4 PREMIUM INSIGHTS 65
4.1 OPHTHALMIC EQUIPMENT MARKET OVERVIEW 65
4.2 NORTH AMERICA: OPHTHALMIC EQUIPMENT MARKET, BY COUNTRY AND
END USER (2024) 66
4.3 OPHTHALMIC EQUIPMENT MARKET: REGIONAL GROWTH OPPORTUNITIES 67
4.4 OPHTHALMIC EQUIPMENT MARKET, BY REGION (2025─2030) 68
4.5 OPHTHALMIC EQUIPMENT MARKET: DEVELOPED VS. DEVELOPING MARKETS 68
5 MARKET OVERVIEW 69
5.1 INTRODUCTION 69
5.2 MARKET DYNAMICS 69
5.2.1 DRIVERS 70
5.2.1.1 Increasing geriatric population 70
5.2.1.2 Rising prevalence of eye disorders 71
5.2.1.2.1 Cataracts 71
5.2.1.2.2 Glaucoma 72
5.2.1.2.3 Obesity and diabetes 73
5.2.1.2.4 Age-related macular degeneration (AMD) 73
5.2.1.3 Technological advancements in ophthalmic devices 74
5.2.1.4 Increased government initiatives to control visual impairment 74
5.2.2 RESTRAINTS 75
5.2.2.1 High cost and risk associated with eye surgeries 75
5.2.2.2 High cost of ophthalmology devices 75
5.2.2.3 Rising adoption of refurbished ophthalmic devices 76
5.2.3 OPPORTUNITIES 77
5.2.3.1 Potential growth opportunities in emerging markets 77
5.2.3.2 Low adoption of phacoemulsification devices and premium IOLs in emerging markets 77
5.2.4 CHALLENGES 78
5.2.4.1 Low accessibility to eye care in low-income countries 78
5.2.4.2 Lack of skilled professionals 78
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 79
5.4 PRICING ANALYSIS 80
5.4.1 AVERAGE SELLING PRICE OF OPHTHLAMIC EQUIPMENT PRODUCTS,
BY KEY PLAYER, 2024 80
5.4.2 AVERAGE SELLING PRICE TREND OF OPTICAL COHERENCE TOMOGRAPHY SYSTEMS, BY REGION, 2022–2024 81
5.5 VALUE CHAIN ANALYSIS 82
5.6 SUPPLY CHAIN ANALYSIS 83
5.7 ECOSYSTEM ANALYSIS 84
5.8 INVESTMENT & FUNDING SCENARIO 85
5.9 TECHNOLOGY ANALYSIS 87
5.9.1 KEY TECHNOLOGIES 87
5.9.1.1 Robotics & image-guided surgical systems 87
5.9.1.2 Wearable and AR/VR-based vision systems 87
5.9.2 COMPLEMENTARY TECHNOLOGIES 88
5.9.2.1 Teleophthalmology and remote monitoring 88
5.9.2.2 Cloud connectivity and data integration 88
5.9.3 ADJACENT TECHNOLOGIES 88
5.9.3.1 Eye-tracking and motion compensation devices 88
5.9.3.2 Data management & EHR integration tools 89
5.10 INDUSTRY TRENDS 89
5.10.1 INNOVATIVE APPLICATION OF FEMTOSECOND LASER TECHNOLOGY 89
5.10.2 MINIMALLY INVASIVE GLAUCOMA SURGERY 90
5.11 PATENT ANALYSIS 90
5.12 TRADE ANALYSIS 92
5.12.1 IMPORT DATA (HS CODE 901850) 92
5.12.2 EXPORT DATA (HS CODE 901850) 93
5.13 KEY CONFERENCES & EVENTS, 2025–2026 94
5.14 CASE STUDY ANALYSIS 95
5.14.1 CASE STUDY 1: ZEISS – AI INTEGRATION IN CIRRUS OCT SYSTEMS 95
5.14.2 CASE STUDY 2: INDIAN GOVERNMENT’S NPCB & USE OF FORUS HEALTH’S 3NETHRA 95
5.14.3 CASE STUDY 3: HEIDELBERG ENGINEERING – NHS UK OCT DEPLOYMENT 96
5.15 REGULATORY ANALYSIS 96
5.15.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 96
5.15.2 REGULATORY LANDSCAPE 98
5.15.2.1 North America 98
5.15.2.1.1 US 98
5.15.2.1.2 Canada 98
5.15.2.2 Europe 99
5.15.2.2.1 Germany 99
5.15.2.2.2 France 99
5.15.2.2.3 UK 99
5.15.2.3 Asia Pacific 99
5.15.2.3.1 China 99
5.15.2.3.2 Japan 99
5.15.2.3.3 India 100
5.15.2.4 Latin America 100
5.15.2.4.1 Brazil 100
5.15.2.4.2 Mexico 100
5.15.2.5 Middle East & Africa 100
5.15.2.5.1 Saudi Arabia 100
5.15.2.5.2 UAE 100
5.15.2.5.3 South Africa 101
5.15.2.5.4 Nigeria 101
5.16 PORTER’S FIVE FORCES ANALYSIS 101
5.16.1 THREAT OF NEW ENTRANTS 103
5.16.2 THREAT OF SUBSTITUTES 103
5.16.3 BARGAINING POWER OF BUYERS 103
5.16.4 BARGAINING POWER OF SUPPLIERS 103
5.16.5 INTENSITY OF COMPETITIVE RIVALRY 104
5.17 KEY STAKEHOLDERS & BUYING CRITERIA 104
5.17.1 KEY STAKEHOLDERS IN BUYING PROCESS 104
5.17.2 BUYING CRITERIA 105
5.18 UNMET NEEDS/END-USER EXPECTATIONS 106
5.19 IMPACT OF 2025 US TARIFFS ON OPHTHALMIC EQUIPMENT MARKET 106
5.19.1 KEY TARIFF RATES 107
5.19.2 PRICE IMPACT ANALYSIS 108
5.19.3 KEY IMPACT ON COUNTRY/REGION 108
5.19.3.1 US 108
5.19.3.2 Europe 108
5.19.3.3 Asia Pacific 109
5.19.4 IMPACT ON END-USER INDUSTRIES 109
5.20 IMPACT OF ARTIFICIAL INTELLIGENCE ON OPHTHALMIC EQUIPMENT MARKET 109
5.21 ADJACENT MARKET ANALYSIS 110
6 OPHTHALMIC EQUIPMENT MARKET, BY TECHNOLOGY 111
6.1 INTRODUCTION 112
6.2 NON-AI-ENABLED EQUIPMENT 112
6.2.1 RISING SURGICAL VOLUMES AND AFFORDABILITY TO DRIVE NON-AI EQUIPMENT ADOPTION 112
6.3 AI-ENABLED EQUIPMENT 114
6.3.1 RISING DEMAND FOR PRECISION DIAGNOSTICS TO ACCELERATE AI-ENABLED EQUIPMENT ADOPTION 114
7 OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT 117
7.1 INTRODUCTION 118
7.2 SURGICAL DEVICES 118
7.2.1 CATARACT SURGICAL DEVICES 120
7.2.1.1 Ophthalmic viscoelastic devices 122
7.2.1.1.1 Increasing number of cataract surgeries to support market growth 122
7.2.1.2 Phacoemulsification devices 125
7.2.1.2.1 Advancements in phacoemulsification devices to increase demand during forecast period 125
7.2.1.3 Cataract surgical lasers 127
7.2.1.3.1 Advantages such as high safety and accuracy to drive market growth 127
7.2.1.4 IOL injectors 129
7.2.1.4.1 Rising need for accurate implantation of IOLs to boost market growth 129
7.2.1.5 Intraocular lenses 131
7.2.1.5.1 Rising prevalence of cataracts globally to propel segment 131
7.2.2 VITREORETINAL SURGICAL DEVICES 134
7.2.2.1 Vitrectomy machines 135
7.2.2.1.1 Extensive usage of vitrectomy machines to correct retinal errors to boost market 135
7.2.2.2 Vitreoretinal packs 137
7.2.2.2.1 Increasing awareness about vitreoretinal surgery to increase utilization of vitreoretinal packs 137
7.2.2.3 Photocoagulation lasers 139
7.2.2.3.1 Rising prevalence of various eye diseases to drive market growth 139
7.2.2.4 Illumination devices 141
7.2.2.4.1 Growing use of portable, powerful illuminators for greater efficiency to fuel market growth 141
7.2.2.5 Vitrectomy probes 143
7.2.2.5.1 Advancements in vitrectomy probes to result in rapid cutting speed to remove vitreous bodies 143
7.2.2.6 Backflushes 145
7.2.2.6.1 Growing use of backflushes to prevent damage or complications to eye structure to propel growth 145
7.2.2.7 Chandeliers 147
7.2.2.7.1 Growing use of chandeliers for improved visualization of retina to aid growth 147
7.2.3 REFRACTIVE SURGICAL DEVICES 149
7.2.3.1 Femtosecond lasers 151
7.2.3.1.1 Rising preference for femtosecond lasers over microkeratomes to support market growth 151
7.2.3.2 Excimer lasers 153
7.2.3.2.1 Rising prevalence of myopia to drive market 153
7.2.3.3 Other refractive surgical devices 155
7.2.4 GLAUCOMA SURGICAL DEVICES 156
7.2.4.1 Microinvasive glaucoma surgery devices 158
7.2.4.1.1 Growing preference for microinvasive glaucoma surgery to drive adoption 158
7.2.4.2 Glaucoma drainage devices 160
7.2.4.2.1 Rising prevalence of glaucoma across globe to drives market growth 160
7.2.4.3 Glaucoma laser systems 162
7.2.4.3.1 Increasing prevalence of open-angle glaucoma to boost segment 162
7.2.5 OPHTHALMIC MICROSCOPES 164
7.2.5.1 Increasing prevalence of eye diseases to drive demand 164
7.2.6 OPHTHALMIC SURGICAL ACCESSORIES 166
7.2.6.1 Surgical instruments & kits 168
7.2.6.1.1 Surgical instruments & kits to hold largest share of accessories market 168
7.2.6.2 Ophthalmic tips & handles 170
7.2.6.2.1 Wide range of tips and handles available to meet end-user demand 170
7.2.6.3 Ophthalmic scissors 171
7.2.6.3.1 Growing end-user preference for titanium scissors to boost market 171
7.2.6.4 Ophthalmic forceps 172
7.2.6.4.1 Wide use of forceps in ophthalmological surgeries to drive demand 172
7.2.6.5 Ophthalmic spatulas 173
7.2.6.5.1 China to be fastest-growing market for ophthalmic spatulas 173
7.2.6.6 Macular lenses 174
7.2.6.6.1 Rise in adoption of macular lenses for hands-free operation to support growth 174
7.2.6.7 Ophthalmic cannulas 175
7.2.6.7.1 Rising adoption of single-use cannulas to drive market growth 175
7.2.6.8 Other ophthalmic surgical accessories 176
7.3 DIAGNOSTIC & MONITORING DEVICES 176
7.3.1 OPTICAL COHERENCE TOMOGRAPHY SCANNERS 178
7.3.1.1 Spectral-domain OCT (SD-OCT) 181
7.3.1.1.1 Growing demand for high-resolution retinal imaging to accelerate spectral-domain OCT adoption 181
7.3.1.2 Swept-source OCT (SS-OCT) 183
7.3.1.2.1 Rising preference for deep tissue imaging and faster scanning to fuel swept-source OCT demand 183
7.3.1.3 Handheld OCT 184
7.3.1.3.1 Surging demand for portability and pediatric imaging to propel handheld OCT system adoption 184
7.3.2 FUNDUS CAMERAS 186
7.3.2.1 Rising prevalence of age-related disorders to boost segment 186
7.3.3 PERIMETERS/VISUAL FIELD ANALYZERS 188
7.3.3.1 Increasing incidence of glaucoma and AMD to drive demand for perimeters 188
7.3.4 AUTOREFRACTORS & KERATOMETERS 190
7.3.4.1 Rising patient population with visual impairment to drive utilization 190
7.3.5 OPHTHALMIC ULTRASOUND IMAGING SYSTEMS 193
7.3.5.1 Ophthalmic A-scan ultrasound 195
7.3.5.1.1 Wide usage to measure length of eye in common eye disorders to boost market 195
7.3.5.2 Ophthalmic B-scan ultrasound 197
7.3.5.2.1 Growing use of B-scans to assess eye and orbit to determine eye disorders 197
7.3.5.3 Ophthalmic ultrasound biomicroscopes 198
7.3.5.3.1 Rising volume of refractive surgeries to fuel market growth 198
7.3.5.4 Ophthalmic pachymeters 201
7.3.5.4.1 Growing use of ophthalmic pachymeters to monitor condition of cornea to support growth 201
7.3.6 OTHER OPHTHALMIC ULTRASOUND IMAGING SYSTEMS 202
7.3.7 TONOMETERS 204
7.3.7.1 Rising prevalence of glaucoma to boost demand 204
7.3.8 SLIT LAMPS 206
7.3.8.1 Rising prevalence of ocular conditions to drive market 206
7.3.9 PHOROPTERS 209
7.3.9.1 Phoropters aid in measurement of refractive errors 209
7.3.10 WAVEFRONT ABERROMETERS 211
7.3.10.1 Effectiveness in measuring refractive aberrations to drive demand 211
7.3.11 OPTICAL BIOMETRY SYSTEMS 213
7.3.11.1 Advantages of optical biometry systems to boost adoption in diagnostics 213
7.3.12 OPHTHALMOSCOPES 215
7.3.12.1 Increasing number of patients with glaucoma, diabetic retinopathy, and AMD to fuel market 215
7.3.13 LENSMETERS 217
7.3.13.1 Rising prevalence of myopia & hyperopia to fuel growth 217
7.3.14 CORNEAL TOPOGRAPHY SYSTEMS 219
7.3.14.1 Increasing number of LASIK procedures to drive demand 219
7.3.15 CHART PROJECTORS 221
7.3.15.1 Ability to provide practitioners access to multiple chart types in one device to boost demand 221
7.3.16 SPECULAR MICROSCOPES 223
7.3.16.1 Growing number of patients with diabetes to drive market 223
7.3.17 RETINOSCOPES 225
7.3.17.1 Rising prevalence of myopia across globe to boost market growth 225
7.3.18 OTHER DIAGNOSTIC & MONITORING DEVICES 227
8 OPHTHALMIC EQUIPMENT MARKET, BY END USER 229
8.1 INTRODUCTION 230
8.2 HOSPITALS 230
8.2.1 LARGE PATIENT POOL AND HIGH PURCHASING POWER OF HOSPITALS TO DRIVE GROWTH 230
8.3 SPECIALTY CLINICS & AMBULATORY SURGERY CENTERS 232
8.3.1 COST-EFFECTIVENESS OF AMBULATORY CARE TO ENHANCE
END-USER INTEREST 232
8.4 OTHER END USERS 233
9 OPHTHALMIC EQUIPMENT MARKET, BY REGION 235
9.1 INTRODUCTION 236
9.2 NORTH AMERICA 237
9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 238
9.2.2 US 244
9.2.2.1 Rising geriatric population and increasing healthcare expenditure to drive market 244
9.2.3 CANADA 251
9.2.3.1 Rising awareness about eye care and increasing ocular diseases to drive market 251
9.3 EUROPE 256
9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 257
9.3.2 GERMANY 262
9.3.2.1 Increasing healthcare expenditure to boost market 262
9.3.3 UK 268
9.3.3.1 Rising prevalence of diabetes-related eye diseases to drive market 268
9.3.4 FRANCE 273
9.3.4.1 Growing number of eye surgeries to drive demand 273
9.3.5 ITALY 279
9.3.5.1 Increasing healthcare spending and growing geriatric population to propel market 279
9.3.6 SPAIN 285
9.3.6.1 Increasing ophthalmic surgical procedures to drive market 285
9.3.7 REST OF EUROPE 290
9.4 ASIA PACIFIC 296
9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 297
9.4.2 CHINA 303
9.4.2.1 Rising prevalence of cataracts to drive market 303
9.4.3 JAPAN 309
9.4.3.1 Strong manufacturing capabilities to propel market 309
9.4.4 INDIA 316
9.4.4.1 Increasing geriatric population and prevalence of eye disorders to support market 316
9.4.5 AUSTRALIA 320
9.4.5.1 Increased cataract surgeries to drive market 320
9.4.6 SOUTH KOREA 326
9.4.6.1 Growing focus on medical tourism to boost market 326
9.4.7 REST OF ASIA PACIFIC 332
9.5 LATIN AMERICA 337
9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 338
9.5.2 BRAZIL 344
9.5.2.1 Government support and initiatives to boost market 344
9.5.3 MEXICO 350
9.5.3.1 Growing incidence of eye disorders to drive market 350
9.5.4 ARGENTINA 356
9.5.4.1 Increasing healthcare expenditure and well-developed healthcare system to favor market 356
9.5.5 REST OF LATIN AMERICA 362
9.6 MIDDLE EAST & AFRICA 369
9.6.1 IMPROVING HEALTHCARE EXPENDITURE TO DRIVE MARKET 369
9.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 369
9.7 GCC COUNTRIES 374
9.7.1 RISING CATARACT PREVALENCE AND ADOPTION OF ADVANCED OPHTHALMIC TECHNOLOGIES TO DRIVE GROWTH 374
9.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES 375
10 COMPETITIVE LANDSCAPE 381
10.1 OVERVIEW 381
10.2 KEY PLAYER STRATEGY/RIGHT TO WIN 381
10.3 REVENUE ANALYSIS, 2020–2024 383
10.4 MARKET SHARE ANALYSIS, 2024 385
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 386
10.5.1 STARS 386
10.5.2 EMERGING LEADERS 386
10.5.3 PERVASIVE PLAYERS 387
10.5.4 PARTICIPANTS 387
10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 388
10.5.5.1 Company footprint 388
10.5.5.2 Region footprint 389
10.5.5.3 Product footprint 390
10.5.5.4 End-user footprint 391
10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 392
10.6.1 PROGRESSIVE COMPANIES 392
10.6.2 RESPONSIVE COMPANIES 392
10.6.3 DYNAMIC COMPANIES 392
10.6.4 STARTING BLOCKS 392
10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 394
10.6.5.1 Detailed list of key startups/SMEs 394
10.6.5.2 Competitive benchmarking of key startups/SMEs 395
10.7 COMPANY VALUATION & FINANCIAL METRICS 396
10.7.1 FINANCIAL METRICS 396
10.7.2 COMPANY VALUATION 396
10.8 BRAND/PRODUCT COMPARISON 397
10.9 COMPETITIVE SCENARIO 398
10.9.1 PRODUCT LAUNCHES & APPROVALS 398
10.9.2 DEALS 400
11 COMPANY PROFILES 404
11.1 KEY PLAYERS 404
11.1.1 ALCON 404
11.1.1.1 Business overview 404
11.1.1.2 Products offered 405
11.1.1.3 Recent developments 406
11.1.1.3.1 Product launches 406
11.1.1.3.2 Deals 407
11.1.1.4 MnM view 407
11.1.1.4.1 Right to win 407
11.1.1.4.2 Strategic choices 407
11.1.1.4.3 Weaknesses & competitive threats 408
11.1.2 JOHNSON & JOHNSON 409
11.1.2.1 Business overview 409
11.1.2.2 Products offered 410
11.1.2.3 Recent developments 412
11.1.2.3.1 Product launches 412
11.1.2.4 MnM view 412
11.1.2.4.1 Right to win 412
11.1.2.4.2 Strategic choices 412
11.1.2.4.3 Weaknesses & competitive threats 412
11.1.3 CARL ZEISS MEDITEC AG 413
11.1.3.1 Business overview 413
11.1.3.2 Products offered 414
11.1.3.3 Recent developments 416
11.1.3.3.1 Product launches 416
11.1.3.3.2 Deals 416
11.1.3.4 MnM view 417
11.1.3.4.1 Right to win 417
11.1.3.4.2 Strategic choices 417
11.1.3.4.3 Weaknesses & competitive threats 417
11.1.4 BAUSCH HEALTH COMPANIES INC. 418
11.1.4.1 Business overview 418
11.1.4.2 Products offered 420
11.1.4.3 Recent developments 420
11.1.4.3.1 Product launches 420
11.1.4.3.2 Deals 421
11.1.4.4 MnM view 421
11.1.4.4.1 Right to win 421
11.1.4.4.2 Strategic choices 421
11.1.4.4.3 Weaknesses & competitive threats 421
11.1.5 HOYA CORPORATION 422
11.1.5.1 Business overview 422
11.1.5.2 Products offered 423
11.1.5.2.1 Deals 424
11.1.5.3 MnM view 425
11.1.5.3.1 Right to win 425
11.1.5.3.2 Strategic choices 425
11.1.5.3.3 Weaknesses & competitive threats 425
11.1.6 ESSILORLUXOTTICA 426
11.1.6.1 Business overview 426
11.1.6.2 Products offered 426
11.1.6.3 Recent developments 428
11.1.6.3.1 Deals 428
11.1.7 CANON 429
11.1.7.1 Business overview 429
11.1.7.2 Products offered 431
11.1.8 GLAUKOS CORPORATION 432
11.1.8.1 Business overview 432
11.1.8.2 Products offered 433
11.1.8.3 Recent developments 434
11.1.8.3.1 Product approvals 434
11.1.8.3.2 Deals 434
11.1.9 TOPCON CORPORATION 435
11.1.9.1 Business overview 435
11.1.9.2 Products offered 436
11.1.9.3 Recent developments 438
11.1.9.3.1 Product launches 438
11.1.9.3.2 Deals 438
11.1.10 NIDEK CO., LTD. 439
11.1.10.1 Business overview 439
11.1.10.2 Products offered 439
11.1.10.3 Recent developments 442
11.1.10.3.1 Product launches 442
11.1.10.3.2 Deals 442
11.1.11 STAAR SURGICAL 443
11.1.11.1 Business overview 443
11.1.11.2 Products offered 444
11.1.11.3 Recent developments 444
11.1.11.3.1 Product approvals 444
11.1.12 HALMA PLC 445
11.1.12.1 Business overview 445
11.1.12.2 Products offered 446
11.1.13 HAAG-STREIT 448
11.1.13.1 Business overview 448
11.1.13.2 Products offered 448
11.1.13.3 Recent developments 449
11.1.13.3.1 Product launches 449
11.1.13.3.2 Deals 450
11.1.14 SHANGHAI MEDIWORKS PRECISION INSTRUMENTS CO., LTD. 451
11.1.14.1 Business overview 451
11.1.14.2 Products offered 451
11.1.15 VISIONIX 452
11.1.15.1 Business overview 452
11.1.15.2 Products offered 452
11.1.15.3 Recent developments 453
11.1.15.3.1 Deals 453
11.2 OTHER PLAYERS 454
11.2.1 VISUNEX MEDICAL SYSTEMS 454
11.2.2 COSTRUZIONE STRUMENTI OFTALMICI 455
11.2.3 HAI LABORATORIES, INC. 456
11.2.4 FORUS HEALTH 457
11.2.5 ZIEMER OPHTHALMIC SYSTEMS AG 458
11.2.6 CRYSTALVUE MEDICAL CORPORATION 459
11.2.7 REMIDIO INNOVATIVE SOLUTIONS PVT. LTD. 460
11.2.8 SUZHOU KANGJIE MEDICAL INC. 461
11.2.9 LUMENIS 462
11.2.10 OPHTEC BV 463
12 APPENDIX 464
12.1 DISCUSSION GUIDE 464
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 470
12.3 CUSTOMIZATION OPTIONS 472
12.4 RELATED REPORTS 472
12.5 AUTHOR DETAILS 473
LIST OF TABLES
TABLE 1 STANDARD CURRENCY CONVERSION RATES 42
TABLE 2 RISK ASSESSMENT: OPHTHALMIC EQUIPMENT MARKET 59
TABLE 3 INCREASE IN GERIATRIC POPULATION, 2000–2050 70
TABLE 4 GLOBAL PREVALENCE OF EYE DISORDERS, BY TYPE, 2024 (IN MILLION) 71
TABLE 5 NUMBER OF CATARACT SURGERIES, BY COUNTRY (2023 VS. 2024) 72
TABLE 6 NUMBER OF GLAUCOMA PATIENTS, BY REGION AND TYPE,
2020 VS. 2040 (MILLION) 72
TABLE 7 NUMBER OF PEOPLE WITH DIABETES, BY REGION, 2030 VS. 2045 (MILLION) 73
TABLE 8 NUMBER OF PEOPLE WITH AGE-RELATED MACULAR DEGENERATION,
BY REGION, 2020 VS. 2050 (MILLION) 74
TABLE 9 PRICE OF OPHTHALMIC EQUIPMENT, BY TYPE (2022) 76
TABLE 10 AVERAGE SELLING PRICE OF OPHTHALMIC EQUIPMENT PRODUCTS,
BY KEY PLAYER, 2024 (USD) 80
TABLE 11 AVERAGE SELLING PRICE TREND OF OPTICAL COHERENCE TOMOGRAPHY SYSTEMS, BY REGION, 2022–2024 (USD) 81
TABLE 12 OPHTHALMIC EQUIPMENT MARKET: ROLE OF COMPANIES IN ECOSYSTEM 85
TABLE 13 IMPORT DATA FOR HS CODE 901850-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD THOUSAND) 92
TABLE 14 EXPORT DATA FOR HS CODE 901890-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD THOUSAND) 93
TABLE 15 OPHTHALMIC EQUIPMENT MARKET: KEY CONFERENCES & EVENTS, 2025–2026 94
TABLE 16 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 96
TABLE 17 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 97
TABLE 18 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 97
TABLE 19 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 97
TABLE 20 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 98
TABLE 21 OPHTHALMIC EQUIPMENT MARKET: PORTER’S FIVE FORCES ANALYSIS 102
TABLE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF OPHTHALMIC EQUIPMENT PRODUCTS 104
TABLE 23 KEY BUYING CRITERIA FOR OPHTHALMIC EQUIPMENT PRODUCTS 105
TABLE 24 US-ADJUSTED RECIPROCAL TARIFF RATES 107
TABLE 25 KEY PRODUCT-RELATED TARIFFS EFFECTIVE FOR ECMO MACHINES 108
TABLE 26 OPHTHALMIC EQUIPMENT MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 112
TABLE 27 NON-AI-ENABLED EQUIPMENT OFFERED BY KEY PLAYERS 113
TABLE 28 NON-AI-ENABLED OPHTHALMIC EQUIPMENT MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 114
TABLE 29 AI-ENABLED EQUIPMENT OFFERED BY KEY PLAYERS 115
TABLE 30 AI-ENABLED OPHTHALMIC EQUIPMENT MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 116
TABLE 31 OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 118
TABLE 32 OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE,
2023–2030 (USD MILLION) 119
TABLE 33 OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY COUNTRY,
2023–2030 (USD MILLION) 120
TABLE 34 CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 121
TABLE 35 CATARACT SURGICAL DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 122
TABLE 36 OPHTHALMIC VISCOELASTIC DEVICES OFFERED BY KEY MARKET PLAYERS 123
TABLE 37 OPHTHALMIC VISCOELASTIC DEVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 124
TABLE 38 OPHTHALMIC VISCOELASTIC DEVICES MARKET, BY REGION, 2023–2030 (UNITS) 125
TABLE 39 PHACOEMULSIFICATION OFFERED BY KEY MARKET PLAYERS 126
TABLE 40 PHACOEMULSIFICATION DEVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 126
TABLE 41 PHACOEMULSIFICATION DEVICES MARKET, BY REGION, 2023–2030 (UNITS) 127
TABLE 42 CATARACT SURGICAL LASERS OFFERED BY KEY MARKET PLAYERS 128
TABLE 43 CATARACT SURGICAL LASERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 128
TABLE 44 CATARACT SURGICAL LASERS MARKET, BY REGION, 2023–2030 (UNITS) 129
TABLE 45 IOL INJECTORS OFFERED BY KEY PLAYERS 129
TABLE 46 IOL INJECTORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 130
TABLE 47 IOL INJECTORS MARKET, BY REGION, 2023–2030 (UNITS) 131
TABLE 48 INTRAOCULAR LENSES OFFERED BY KEY PLAYERS 132
TABLE 49 INTRAOCULAR LENSES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 133
TABLE 50 INTRAOCULAR LENSES MARKET, BY REGION, 2023–2030 (UNITS) 133
TABLE 51 VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 134
TABLE 52 VITREORETINAL SURGICAL DEVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 135
TABLE 53 VITRECTOMY MACHINES OFFERED BY KEY MARKET PLAYERS 136
TABLE 54 VITRECTOMY MACHINES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 136
TABLE 55 VITRECTOMY MACHINES MARKET, BY REGION, 2023–2030 (UNITS) 137
TABLE 56 VITREORETINAL PACKS OFFERED BY KEY MARKET PLAYERS 137
TABLE 57 VITREORETINAL PACKS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 138
TABLE 58 VITREORETINAL PACKS MARKET, BY REGION, 2023–2030 (UNITS) 138
TABLE 59 PHOTOCOAGULATION LASERS OFFERED BY KEY MARKET PLAYERS 139
TABLE 60 PHOTOCOAGULATION LASERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 140
TABLE 61 PHOTOCOAGULATION LASERS MARKET, BY REGION, 2023–2030 (UNITS) 141
TABLE 62 ILLUMINATION DEVICES OFFERED BY KEY MARKET PLAYERS 141
TABLE 63 ILLUMINATION DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 142
TABLE 64 ILLUMINATION DEVICES MARKET, BY REGION, 2023–2030 (UNITS) 143
TABLE 65 VITRECTOMY PROBES OFFERED BY KEY MARKET PLAYERS 143
TABLE 66 VITRECTOMY PROBES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 144
TABLE 67 VITRECTOMY PROBES MARKET, BY REGION, 2023–2030 (UNITS) 145
TABLE 68 BACKFLUSHES OFFERED BY KEY MARKET PLAYERS 145
TABLE 69 BACKFLUSHES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 146
TABLE 70 BACKFLUSHES MARKET, BY REGION, 2023–2030 (UNITS) 147
TABLE 71 CHANDELIERS OFFERED BY KEY MARKET PLAYERS 147
TABLE 72 CHANDELIERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 148
TABLE 73 CHANDELIERS MARKET, BY REGION, 2023–2030 (UNITS) 149
TABLE 74 REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 150
TABLE 75 REFRACTIVE SURGICAL DEVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 150
TABLE 76 FEMTOSECOND LASERS OFFERED BY KEY MARKET PLAYERS 151
TABLE 77 FEMTOSECOND LASERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 152
TABLE 78 FEMTOSECOND LASERS MARKET, BY REGION, 2023–2030 (UNITS) 153
TABLE 79 EXCIMER LASERS OFFERED BY KEY MARKET PLAYERS 154
TABLE 80 EXCIMER LASERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 154
TABLE 81 EXCIMER LASERS MARKET, BY REGION, 2023–2030 (UNITS) 155
TABLE 82 OTHER REFRACTIVE SURGICAL DEVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 156
TABLE 83 GLAUCOMA SURGICAL DEVICES OFFERED BY KEY MARKET PLAYERS 157
TABLE 84 GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 157
TABLE 85 GLAUCOMA SURGICAL DEVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 158
TABLE 86 MICROINVASIVE GLAUCOMA SURGERY DEVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 159
TABLE 87 MICROINVASIVE GLAUCOMA SURGERY DEVICES MARKET, BY REGION,
2023–2030 (UNITS) 160
TABLE 88 GLAUCOMA DRAINAGE DEVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 161
TABLE 89 GLAUCOMA DRAINAGE DEVICES MARKET, BY REGION, 2023–2030 (UNITS) 162
TABLE 90 GLAUCOMA LASER SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 163
TABLE 91 GLAUCOMA LASER SYSTEMS MARKET, BY REGION, 2023–2030 (UNITS) 164
TABLE 92 OPHTHALMIC MICROSCOPES OFFERED BY KEY MARKET PLAYERS 165
TABLE 93 OPHTHALMIC MICROSCOPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 165
TABLE 94 OPHTHALMIC SURGICAL ACCESSORIES OFFERED BY KEY MARKET PLAYERS 166
TABLE 95 OPHTHALMIC SURGICAL ACCESSORIES MARKET, BY TYPE,
2023–2030 (USD MILLION) 167
TABLE 96 OPHTHALMIC SURGICAL ACCESSORIES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 168
TABLE 97 SURGICAL INSTRUMENTS & KITS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 169
TABLE 98 OPHTHALMIC TIPS & HANDLES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 170
TABLE 99 OPHTHALMIC SCISSORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 171
TABLE 100 OPHTHALMIC FORCEPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 172
TABLE 101 OPHTHALMIC SPATULAS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 173
TABLE 102 MACULAR LENSES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 174
TABLE 103 OPHTHALMIC CANNULAS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 175
TABLE 104 OTHER OPHTHALMIC SURGICAL ACCESSORIES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 176
TABLE 105 OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES,
BY TYPE, 2023–2030 (USD MILLION) 177
TABLE 106 OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES,
BY COUNTRY, 2023–2030 (USD MILLION) 178
TABLE 107 OCT SCANNERS OFFERED BY KEY MARKET PLAYERS 179
TABLE 108 OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 180
TABLE 109 OPTICAL COHERENCE TOMOGRAPHY SCANNERS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 180
TABLE 110 OPTICAL COHERENCE TOMOGRAPHY SCANNERS MARKET, BY REGION,
2023–2030 (UNITS) 181
TABLE 111 SPECTRAL-DOMAIN OCT (SD-OCT) SYSTEMS OFFERED BY KEY MARKET PLAYERS 182
TABLE 112 SPECTRAL-DOMAIN OCT (SD-OCT) MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 182
TABLE 113 SWEPT-SOURCE OCT (SS-OCT) SYSTEMS OFFERED BY KEY MARKET PLAYERS 183
TABLE 114 SWEPT-SOURCE OCT (SS-OCT) MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 184
TABLE 115 EXAMPLES OF HANDHELD OCT 185
TABLE 116 HANDHELD OCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 185
TABLE 117 FUNDUS CAMERAS OFFERED BY KEY MARKET PLAYERS 186
TABLE 118 FUNDUS CAMERAS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 187
TABLE 119 FUNDUS CAMERAS MARKET, BY REGION, 2023–2030 (UNITS) 188
TABLE 120 PERIMETERS/VISUAL FIELD ANALYZERS OFFERED BY KEY MARKET PLAYERS 189
TABLE 121 PERIMETERS/VISUAL FIELD ANALYZERS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 189
TABLE 122 PERIMETERS/VISUAL FIELD ANALYZERS MARKET, BY REGION,
2023–2030 (UNITS) 190
TABLE 123 AUTOREFRACTORS & KERATOMETERS OFFERED BY KEY MARKET PLAYERS 191
TABLE 124 AUTOREFRACTORS & KERATOMETERS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 192
TABLE 125 AUTOREFRACTORS & KERATOMETERS MARKET, BY REGION, 2023–2030 (UNITS) 193
TABLE 126 OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 194
TABLE 127 OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 194
TABLE 128 OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET, BY REGION,
2023–2030 (UNITS) 195
TABLE 129 OPHTHALMIC A-SCAN ULTRASOUND SYSTEMS OFFERED BY KEY MARKET PLAYERS 196
TABLE 130 OPHTHALMIC A-SCAN ULTRASOUND MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 196
TABLE 131 OPHTHALMIC B-SCAN ULTRASOUND SYSTEMS OFFERED BY KEY MARKET PLAYERS 197
TABLE 132 OPHTHALMIC B-SCAN ULTRASOUND MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 198
TABLE 133 OPHTHALMIC ULTRASOUND BIOMICROSCOPES OFFERED
BY KEY MARKET PLAYERS 199
TABLE 134 OPHTHALMIC ULTRASOUND BIOMICROSCOPES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 200
TABLE 135 OPHTHALMIC PACHYMETERS OFFERED BY KEY MARKET PLAYERS 201
TABLE 136 OPHTHALMIC PACHYMETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 202
TABLE 137 OTHER OPHTHALMIC ULTRASOUND IMAGING SYSTEMS OFFERED BY KEY MARKET PLAYERS 203
TABLE 138 OTHER OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 203
TABLE 139 TONOMETERS OFFERED BY KEY MARKET PLAYERS 204
TABLE 140 TONOMETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 205
TABLE 141 TONOMETERS MARKET, BY REGION, 2023–2030 (UNITS) 206
TABLE 142 SLIT LAMPS OFFERED BY KEY MARKET PLAYERS 207
TABLE 143 SLIT LAMPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 208
TABLE 144 SLIT LAMPS MARKET, BY REGION, 2023–2030 (UNITS) 209
TABLE 145 PHOROPTERS OFFERED BY KEY MARKET PLAYERS 209
TABLE 146 PHOROPTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 210
TABLE 147 PHOROPTERS MARKET, BY REGION, 2023–2030 (UNITS) 211
TABLE 148 WAVEFRONT ABERROMETERS OFFERED BY KEY MARKET PLAYERS 211
TABLE 149 WAVEFRONT ABERROMETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 212
TABLE 150 WAVEFRONT ABERROMETERS MARKET, BY REGION, 2023–2030 (UNITS) 213
TABLE 151 OPTICAL BIOMETRY SYSTEMS OFFERED BY KEY MARKET PLAYERS 214
TABLE 152 OPTICAL BIOMETRY SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 214
TABLE 153 OPTICAL BIOMETRY SYSTEMS MARKET, BY REGION, 2023–2030 (UNITS) 215
TABLE 154 OPHTHALMOSCOPES OFFERED BY KEY MARKET PLAYERS 216
TABLE 155 OPHTHALMOSCOPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 216
TABLE 156 OPHTHALMOSCOPES MARKET, BY REGION, 2023–2030 (UNITS) 217
TABLE 157 LENSMETERS OFFERED BY KEY MARKET PLAYERS 217
TABLE 158 LENSMETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 218
TABLE 159 LENSMETERS MARKET, BY REGION, 2023–2030 (UNITS) 219
TABLE 160 CORNEAL TOPOGRAPHY SYSTEMS OFFERED BY KEY MARKET PLAYERS 219
TABLE 161 CORNEAL TOPOGRAPHY SYSTEMS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 220
TABLE 162 CORNEAL TOPOGRAPHY SYSTEMS MARKET, BY REGION,
2023–2030 (UNITS) 220
TABLE 163 CHART PROJECTORS OFFERED BY KEY MARKET PLAYERS 221
TABLE 164 CHART PROJECTORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 222
TABLE 165 CHART PROJECTORS MARKET, BY REGION, 2023–2030 (UNITS) 222
TABLE 166 SPECULAR MICROSCOPES OFFERED BY KEY MARKET PLAYERS 223
TABLE 167 SPECULAR MICROSCOPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 224
TABLE 168 SPECULAR MICROSCOPES MARKET, BY REGION, 2023–2030 (UNITS) 224
TABLE 169 RETINOSCOPES OFFERED BY KEY MARKET PLAYERS 225
TABLE 170 RETINOSCOPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 226
TABLE 171 RETINOSCOPES MARKET, BY REGION, 2023–2030 (UNITS) 226
TABLE 172 OTHER DIAGNOSTIC & MONITORING DEVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 228
TABLE 173 OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2023–2030 (USD MILLION) 230
TABLE 174 OPHTHALMIC EQUIPMENT MARKET FOR HOSPITALS, BY COUNTRY,
2023–2030 (USD MILLION) 231
TABLE 175 OPHTHALMIC EQUIPMENT MARKET FOR SPECIALTY CLINICS & AMBULATORY SURGERY CENTERS, BY COUNTRY, 2023–2030 (USD MILLION) 233
TABLE 176 OPHTHALMIC EQUIPMENT MARKET FOR OTHER END USERS, BY COUNTRY,
2023–2030 (USD MILLION) 234
TABLE 177 OPHTHALMIC EQUIPMENT MARKET, BY REGION, 2023–2030 (USD MILLION) 236
TABLE 178 NORTH AMERICA: OPHTHALMIC EQUIPMENT MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 239
TABLE 179 NORTH AMERICA: OPHTHALMIC EQUIPMENT MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 239
TABLE 180 NORTH AMERICA: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 239
TABLE 181 NORTH AMERICA: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2023–2030 (USD MILLION) 240
TABLE 182 NORTH AMERICA: OPTICAL COHERENCE TOMOGRAPHY SCANNERS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 240
TABLE 183 NORTH AMERICA: OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 241
TABLE 184 NORTH AMERICA: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES,
BY TYPE, 2023–2030 (USD MILLION) 241
TABLE 185 NORTH AMERICA: CATARACT SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 242
TABLE 186 NORTH AMERICA: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 242
TABLE 187 NORTH AMERICA: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 243
TABLE 188 NORTH AMERICA: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 243
TABLE 189 NORTH AMERICA: OPHTHALMIC EQUIPMENT MARKET, BY END USER,
2023–2030 (USD MILLION) 244
TABLE 190 US: OPHTHALMIC EQUIPMENT MARKET, VOLUME, 2023–2030 (UNITS) 245
TABLE 191 US: OPHTHALMIC EQUIPMENT MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 246
TABLE 192 US: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 246
TABLE 193 US: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2023–2030 (USD MILLION) 247
TABLE 194 US: OPTICAL COHERENCE TOMOGRAPHY SCANNERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 248
TABLE 195 US: OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 248
TABLE 196 US: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE,
2023–2030 (USD MILLION) 249
TABLE 197 US: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 249
TABLE 198 US: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 250
TABLE 199 US: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 250
TABLE 200 US: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 250
TABLE 201 US: OPHTHALMIC EQUIPMENT MARKET, BY END USER,
2023–2030 (USD MILLION) 251
TABLE 202 CANADA: OPHTHALMIC EQUIPMENT MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 252
TABLE 203 CANADA: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 252
TABLE 204 CANADA: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2023–2030 (USD MILLION) 253
TABLE 205 CANADA: OPTICAL COHERENCE TOMOGRAPHY SCANNERS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 253
TABLE 206 CANADA: OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 254
TABLE 207 CANADA: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES,
BY TYPE, 2023–2030 (USD MILLION) 254
TABLE 208 CANADA: CATARACT SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 255
TABLE 209 CANADA: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 255
TABLE 210 CANADA: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 255
TABLE 211 CANADA: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 256
TABLE 212 CANADA: OPHTHALMIC EQUIPMENT MARKET, BY END USER,
2023–2030 (USD MILLION) 256
TABLE 213 EUROPE: OPHTHALMIC EQUIPMENT MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 257
TABLE 214 EUROPE: OPHTHALMIC EQUIPMENT MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 257
TABLE 215 EUROPE: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 258
TABLE 216 EUROPE: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2023–2030 (USD MILLION) 258
TABLE 217 EUROPE: OPTICAL COHERENCE TOMOGRAPHY SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 259
TABLE 218 EUROPE: OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 259
TABLE 219 EUROPE: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2023–2030 (USD MILLION) 260
TABLE 220 EUROPE: CATARACT SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 260
TABLE 221 EUROPE: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 261
TABLE 222 EUROPE: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 261
TABLE 223 EUROPE: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 262
TABLE 224 EUROPE: OPHTHALMIC EQUIPMENT MARKET, BY END USER,
2023–2030 (USD MILLION) 262
TABLE 225 GERMANY: OPHTHALMIC EQUIPMENT MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 263
TABLE 226 GERMANY: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 263
TABLE 227 GERMANY: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2023–2030 (USD MILLION) 264
TABLE 228 GERMANY: OPTICAL COHERENCE TOMOGRAPHY SCANNERS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 264
TABLE 229 GERMANY: OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 265
TABLE 230 GERMANY: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2023–2030 (USD MILLION) 265
TABLE 231 GERMANY: CATARACT SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 266
TABLE 232 GERMANY: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 266
TABLE 233 GERMANY: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 267
TABLE 234 GERMANY: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 267
TABLE 235 GERMANY: OPHTHALMIC EQUIPMENT MARKET, BY END USER,
2023–2030 (USD MILLION) 268
TABLE 236 UK: OPHTHALMIC EQUIPMENT MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 269
TABLE 237 UK: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 269
TABLE 238 UK: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2023–2030 (USD MILLION) 270
TABLE 239 UK: OPTICAL COHERENCE TOMOGRAPHY SCANNERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 270
TABLE 240 UK: OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 271
TABLE 241 UK: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE,
2023–2030 (USD MILLION) 271
TABLE 242 UK: CATARACT SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 272
TABLE 243 UK: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 272
TABLE 244 UK: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 272
TABLE 245 UK: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 273
TABLE 246 UK: OPHTHALMIC EQUIPMENT MARKET, BY END USER,
2023–2030 (USD MILLION) 273
TABLE 247 FRANCE: OPHTHALMIC EQUIPMENT MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 274
TABLE 248 FRANCE: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 274
TABLE 249 FRANCE: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2023–2030 (USD MILLION) 275
TABLE 250 FRANCE: OPTICAL COHERENCE TOMOGRAPHY SCANNERS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 276
TABLE 251 FRANCE: OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 276
TABLE 252 FRANCE: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES,
BY TYPE, 2023–2030 (USD MILLION) 277
TABLE 253 FRANCE: CATARACT SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 277
TABLE 254 FRANCE: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 278
TABLE 255 FRANCE: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 278
TABLE 256 FRANCE: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 279
TABLE 257 FRANCE: OPHTHALMIC EQUIPMENT MARKET, BY END USER,
2023–2030 (USD MILLION) 279
TABLE 258 ITALY: OPHTHALMIC EQUIPMENT MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 280
TABLE 259 ITALY: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 280
TABLE 260 ITALY: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2023–2030 (USD MILLION) 281
TABLE 261 ITALY: OPTICAL COHERENCE TOMOGRAPHY SCANNERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 282
TABLE 262 ITALY: OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 282
TABLE 263 ITALY: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2023–2030 (USD MILLION) 283
TABLE 264 ITALY: CATARACT SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 283
TABLE 265 ITALY: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 284
TABLE 266 ITALY: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 284
TABLE 267 ITALY: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 284
TABLE 268 ITALY: OPHTHALMIC EQUIPMENT MARKET, BY END USER,
2023–2030 (USD MILLION) 285
TABLE 269 SPAIN: OPHTHALMIC EQUIPMENT MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 285
TABLE 270 SPAIN: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 286
TABLE 271 SPAIN: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2023–2030 (USD MILLION) 286
TABLE 272 SPAIN: OPTICAL COHERENCE TOMOGRAPHY SCANNERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 287
TABLE 273 SPAIN: OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 287
TABLE 274 SPAIN: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2023–2030 (USD MILLION) 288
TABLE 275 SPAIN: CATARACT SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 288
TABLE 276 SPAIN: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 289
TABLE 277 SPAIN: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 289
TABLE 278 SPAIN: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 290
TABLE 279 SPAIN: OPHTHALMIC EQUIPMENT MARKET, BY END USER,
2023–2030 (USD MILLION) 290
TABLE 280 REST OF EUROPE: OPHTHALMIC EQUIPMENT MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 291
TABLE 281 REST OF EUROPE: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 291
TABLE 282 REST OF EUROPE: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2023–2030 (USD MILLION) 292
TABLE 283 REST OF EUROPE: OPTICAL COHERENCE TOMOGRAPHY SCANNERS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 292
TABLE 284 REST OF EUROPE: OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 293
TABLE 285 REST OF EUROPE: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL
DEVICES, BY TYPE, 2023–2030 (USD MILLION) 293
TABLE 286 REST OF EUROPE: CATARACT SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 294
TABLE 287 REST OF EUROPE: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 294
TABLE 288 REST OF EUROPE: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 295
TABLE 289 REST OF EUROPE: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 295
TABLE 290 REST OF EUROPE: OPHTHALMIC EQUIPMENT MARKET, BY END USER,
2023–2030 (USD MILLION) 296
TABLE 291 ASIA PACIFIC: OPHTHALMIC EQUIPMENT MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 298
TABLE 292 ASIA PACIFIC: OPHTHALMIC EQUIPMENT MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 298
TABLE 293 ASIA PACIFIC: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 298
TABLE 294 ASIA PACIFIC: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2023–2030 (USD MILLION) 299
TABLE 295 ASIA PACIFIC: OPTICAL COHERENCE TOMOGRAPHY SCANNERS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 299
TABLE 296 ASIA PACIFIC: OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 300
TABLE 297 ASIA PACIFIC: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES,
BY TYPE, 2023–2030 (USD MILLION) 300
TABLE 298 ASIA PACIFIC: CATARACT SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 301
TABLE 299 ASIA PACIFIC: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 301
TABLE 300 ASIA PACIFIC: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 302
TABLE 301 ASIA PACIFIC: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 302
TABLE 302 ASIA PACIFIC: OPHTHALMIC EQUIPMENT MARKET, BY END USER,
2023–2030 (USD MILLION) 303
TABLE 303 CHINA: OPHTHALMIC EQUIPMENT MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 304
TABLE 304 CHINA: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 304
TABLE 305 CHINA: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2023–2030 (USD MILLION) 305
TABLE 306 CHINA: OPTICAL COHERENCE TOMOGRAPHY SCANNERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 306
TABLE 307 CHINA: OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 306
TABLE 308 CHINA: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL
DEVICES, BY TYPE, 2023–2030 (USD MILLION) 307
TABLE 309 CHINA: CATARACT SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 307
TABLE 310 CHINA: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 308
TABLE 311 CHINA: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 308
TABLE 312 CHINA: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 309
TABLE 313 CHINA: OPHTHALMIC EQUIPMENT MARKET, BY END USER,
2023–2030 (USD MILLION) 309
TABLE 314 JAPAN: OPHTHALMIC EQUIPMENT MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 310
TABLE 315 JAPAN: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 310
TABLE 316 JAPAN: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2023–2030 (USD MILLION) 311
TABLE 317 JAPAN: OPTICAL COHERENCE TOMOGRAPHY SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 312
TABLE 318 JAPAN: OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 312
TABLE 319 JAPAN: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES,
BY TYPE, 2023–2030 (USD MILLION) 313
TABLE 320 JAPAN: CATARACT SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 313
TABLE 321 JAPAN: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 314
TABLE 322 JAPAN: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 314
TABLE 323 JAPAN: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 315
TABLE 324 JAPAN: OPHTHALMIC EQUIPMENT MARKET, BY END USER,
2023–2030 (USD MILLION) 315
TABLE 325 INDIA: OPHTHALMIC EQUIPMENT MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 316
TABLE 326 INDIA: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 316
TABLE 327 INDIA: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2023–2030 (USD MILLION) 317
TABLE 328 INDIA: OPTICAL COHERENCE TOMOGRAPHY SCANNERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 317
TABLE 329 INDIA: OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 318
TABLE 330 INDIA: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2023–2030 (USD MILLION) 318
TABLE 331 INDIA: CATARACT SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 319
TABLE 332 INDIA: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 319
TABLE 333 INDIA: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 319
TABLE 334 INDIA: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 320
TABLE 335 INDIA: OPHTHALMIC EQUIPMENT MARKET, BY END USER,
2023–2030 (USD MILLION) 320
TABLE 336 AUSTRALIA: OPHTHALMIC EQUIPMENT MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 321
TABLE 337 AUSTRALIA: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 321
TABLE 338 AUSTRALIA: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2023–2030 (USD MILLION) 322
TABLE 339 AUSTRALIA: OPTICAL COHERENCE TOMOGRAPHY SCANNERS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 322
TABLE 340 AUSTRALIA: OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 323
TABLE 341 AUSTRALIA: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES,
BY TYPE, 2023–2030 (USD MILLION) 323
TABLE 342 AUSTRALIA: CATARACT SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 324
TABLE 343 AUSTRALIA: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 324
TABLE 344 AUSTRALIA: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 325
TABLE 345 AUSTRALIA: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 325
TABLE 346 AUSTRALIA: OPHTHALMIC EQUIPMENT MARKET, BY END USER,
2023–2030 (USD MILLION) 326
TABLE 347 SOUTH KOREA: OPHTHALMIC EQUIPMENT MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 327
TABLE 348 SOUTH KOREA: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 327
TABLE 349 SOUTH KOREA: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2023–2030 (USD MILLION) 328
TABLE 350 SOUTH KOREA: OPTICAL COHERENCE TOMOGRAPHY SCANNERS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 328
TABLE 351 SOUTH KOREA: OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 329
TABLE 352 SOUTH KOREA: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES,
BY TYPE, 2023–2030 (USD MILLION) 329
TABLE 353 SOUTH KOREA: CATARACT SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 330
TABLE 354 SOUTH KOREA: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 330
TABLE 355 SOUTH KOREA: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 331
TABLE 356 SOUTH KOREA: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 331
TABLE 357 SOUTH KOREA: OPHTHALMIC EQUIPMENT MARKET, BY END USER,
2023–2030 (USD MILLION) 332
TABLE 358 REST OF ASIA PACIFIC: OPHTHALMIC EQUIPMENT MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 332
TABLE 359 REST OF ASIA PACIFIC: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 333
TABLE 360 REST OF ASIA PACIFIC: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2023–2030 (USD MILLION) 333
TABLE 361 REST OF ASIA PACIFIC: OPTICAL COHERENCE TOMOGRAPHY SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 334
TABLE 362 REST OF ASIA PACIFIC: OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 334
TABLE 363 REST OF ASIA PACIFIC: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2023–2030 (USD MILLION) 335
TABLE 364 REST OF ASIA PACIFIC: CATARACT SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 335
TABLE 365 REST OF ASIA PACIFIC: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 336
TABLE 366 REST OF ASIA PACIFIC: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 336
TABLE 367 REST OF ASIA PACIFIC: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 337
TABLE 368 REST OF ASIA PACIFIC: OPHTHALMIC EQUIPMENT MARKET, BY END USER,
2023–2030 (USD MILLION) 337
TABLE 369 LATIN AMERICA: OPHTHALMIC EQUIPMENT MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 338
TABLE 370 LATIN AMERICA: OPHTHALMIC EQUIPMENT MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 339
TABLE 371 LATIN AMERICA: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 339
TABLE 372 LATIN AMERICA: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2023–2030 (USD MILLION) 340
TABLE 373 LATIN AMERICA: OPTICAL COHERENCE TOMOGRAPHY SCANNERS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 341
TABLE 374 LATIN AMERICA: OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 341
TABLE 375 LATIN AMERICA: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES,
BY TYPE, 2023–2030 (USD MILLION) 342
TABLE 376 LATIN AMERICA: CATARACT SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 342
TABLE 377 LATIN AMERICA: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 343
TABLE 378 LATIN AMERICA: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 343
TABLE 379 LATIN AMERICA: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 344
TABLE 380 LATIN AMERICA: OPHTHALMIC EQUIPMENT MARKET, BY END USER,
2023–2030 (USD MILLION) 344
TABLE 381 BRAZIL: OPHTHALMIC EQUIPMENT MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 345
TABLE 382 BRAZIL: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 345
TABLE 383 BRAZIL: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2023–2030 (USD MILLION) 346
TABLE 384 BRAZIL: OPTICAL COHERENCE TOMOGRAPHY SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 347
TABLE 385 BRAZIL: OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET, BY TYPE,
2023–2030 (USD MILLION) 347
TABLE 386 BRAZIL: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2023–2030 (USD MILLION) 348
TABLE 387 BRAZIL: CATARACT SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 348
TABLE 388 BRAZIL: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 349
TABLE 389 BRAZIL: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 349
TABLE 390 BRAZIL: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 350
TABLE 391 BRAZIL: OPHTHALMIC EQUIPMENT MARKET, BY END USER,
2023–2030 (USD MILLION) 350
TABLE 392 MEXICO: OPHTHALMIC EQUIPMENT MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 351
TABLE 393 MEXICO: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 351
TABLE 394 MEXICO: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2023–2030 (USD MILLION) 352
TABLE 395 MEXICO: OPTICAL COHERENCE TOMOGRAPHY SCANNERS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 353
TABLE 396 MEXICO: OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 353
TABLE 397 MEXICO: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES,
BY TYPE, 2023–2030 (USD MILLION) 354
TABLE 398 MEXICO: CATARACT SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 354
TABLE 399 MEXICO: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 355
TABLE 400 MEXICO: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 355
TABLE 401 MEXICO: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 356
TABLE 402 MEXICO: OPHTHALMIC EQUIPMENT MARKET, BY END USER,
2023–2030 (USD MILLION) 356
TABLE 403 ARGENTINA: OPHTHALMIC EQUIPMENT MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 357
TABLE 404 ARGENTINA: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 357
TABLE 405 ARGENTINA: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2023–2030 (USD MILLION) 358
TABLE 406 ARGENTINA: OPTICAL COHERENCE TOMOGRAPHY SCANNERS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 359
TABLE 407 ARGENTINA: OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 359
TABLE 408 ARGENTINA: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES,
BY TYPE, 2023–2030 (USD MILLION) 360
TABLE 409 ARGENTINA: CATARACT SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 360
TABLE 410 ARGENTINA: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 361
TABLE 411 ARGENTINA: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 361
TABLE 412 ARGENTINA: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 362
TABLE 413 ARGENTINA: OPHTHALMIC EQUIPMENT MARKET, BY END USER,
2023–2030 (USD MILLION) 362
TABLE 414 REST OF LATIN AMERICA: OPHTHALMIC EQUIPMENT MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 363
TABLE 415 REST OF LATIN AMERICA: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 363
TABLE 416 REST OF LATIN AMERICA: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2023–2030 (USD MILLION) 364
TABLE 417 REST OF LATIN AMERICA: OPTICAL COHERENCE TOMOGRAPHY SCANNERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 365
TABLE 418 REST OF LATIN AMERICA: OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 365
TABLE 419 REST OF LATIN AMERICA: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2023–2030 (USD MILLION) 366
TABLE 420 REST OF LATIN AMERICA: CATARACT SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 366
TABLE 421 REST OF LATIN AMERICA: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 367
TABLE 422 REST OF LATIN AMERICA: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 367
TABLE 423 REST OF LATIN AMERICA: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 368
TABLE 424 REST OF LATIN AMERICA: OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2023–2030 (USD MILLION) 368
TABLE 425 MIDDLE EAST & AFRICA: OPHTHALMIC EQUIPMENT MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 369
TABLE 426 MIDDLE EAST & AFRICA: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 370
TABLE 427 MIDDLE EAST & AFRICA: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2023–2030 (USD MILLION) 370
TABLE 428 MIDDLE EAST & AFRICA: OPTICAL COHERENCE TOMOGRAPHY SCANNERS MARKET, BY TYPE,2023–2030 (USD MILLION) 371
TABLE 429 MIDDLE EAST & AFRICA: OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET, BY TYPE,2023–2030 (USD MILLION) 371
TABLE 430 MIDDLE EAST & AFRICA: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE, 2023–2030 (USD MILLION) 372
TABLE 431 MIDDLE EAST & AFRICA: CATARACT SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 372
TABLE 432 MIDDLE EAST & AFRICA: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 373
TABLE 433 MIDDLE EAST & AFRICA: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 373
TABLE 434 MIDDLE EAST & AFRICA: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 374
TABLE 435 MIDDLE EAST & AFRICA: OPHTHALMIC EQUIPMENT MARKET, BY END USER,
2023–2030 (USD MILLION) 374
TABLE 436 GCC COUNTRIES: OPHTHALMIC EQUIPMENT MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 375
TABLE 437 GCC COUNTRIES: OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 376
TABLE 438 GCC COUNTRIES: OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES, BY TYPE, 2023–2030 (USD MILLION) 376
TABLE 439 GCC COUNTRIES: OPTICAL COHERENCE TOMOGRAPHY SCANNERS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 377
TABLE 440 GCC COUNTRIES: OPHTHALMIC ULTRASOUND IMAGING SYSTEMS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 377
TABLE 441 GCC COUNTRIES: OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL
DEVICES, BY TYPE, 2023–2030 (USD MILLION) 378
TABLE 442 GCC COUNTRIES: CATARACT SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 378
TABLE 443 GCC COUNTRIES: GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 379
TABLE 444 GCC COUNTRIES: REFRACTIVE SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 379
TABLE 445 GCC COUNTRIES: VITREORETINAL SURGICAL DEVICES MARKET, BY TYPE,
2023–2030 (USD MILLION) 380
TABLE 446 GCC COUNTRIES: OPHTHALMIC EQUIPMENT MARKET, BY END USER,
2023–2030 (USD MILLION) 380
TABLE 447 KEY DEVELOPMENTS IN OPHTHALMIC EQUIPMENT MARKET,
JANUARY 2021–OCTOBER 2025 381
TABLE 448 OPHTHALMIC EQUIPMENT MARKET: DEGREE OF COMPETITION 385
TABLE 449 OPHTHALMIC EQUIPMENT MARKET: REGION FOOTPRINT 389
TABLE 450 OPHTHALMIC EQUIPMENT MARKET: PRODUCT FOOTPRINT 390
TABLE 451 OPHTHALMIC EQUIPMENT MARKET: END-USER FOOTPRINT 391
TABLE 452 OPHTHALMIC EQUIPMENT MARKET: DETAILED LIST OF KEY STARTUPS/SMES 394
TABLE 453 OPHTHALMIC EQUIPMENT MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES 395
TABLE 454 OPHTHALMIC EQUIPMENT MARKET: PRODUCT LAUNCHES &
APPROVALS, JANUARY 2021–OCTOBER 2025 398
TABLE 455 OPHTHALMIC EQUIPMENT MARKET: DEALS, JANUARY 2021–OCTOBER 2025 400
TABLE 456 ALCON: COMPANY OVERVIEW 404
TABLE 457 ALCON: PRODUCTS OFFERED 405
TABLE 458 ALCON: PRODUCT LAUNCHES, JANUARY 2021–OCTOBER 2025 406
TABLE 459 ALCON: DEALS, JANUARY 2021–OCTOBER 2025 407
TABLE 460 JOHNSON & JOHNSON: COMPANY OVERVIEW 409
TABLE 461 JOHNSON & JOHNSON: PRODUCTS OFFERED 410
TABLE 462 JOHNSON & JOHNSON: PRODUCT LAUNCHES, JANUARY 2021–OCTOBER 2025 412
TABLE 463 CARL ZEISS MEDITEC AG: COMPANY OVERVIEW 413
TABLE 464 CARL ZEISS MEDITEC AG: PRODUCTS OFFERED 414
TABLE 465 CARL ZEISS MEDITEC AG: PRODUCT LAUNCHES, JANUARY 2021–OCTOBER 2025 416
TABLE 466 CARL ZEISS MEDITEC AG: DEALS, JANUARY 2021–OCTOBER 2025 416
TABLE 467 BAUSCH HEALTH COMPANIES INC.: COMPANY OVERVIEW 418
TABLE 468 BAUSCH HEALTH COMPANIES INC.: PRODUCTS OFFERED 420
TABLE 469 BAUSCH HEALTH COMPANIES INC.: PRODUCT LAUNCHES,
JANUARY 2021–OCTOBER 2025 420
TABLE 470 BAUSCH HEALTH COMPANIES INC.: DEALS, JANUARY 2021–OCTOBER 2025 421
TABLE 471 HOYA CORPORATION: COMPANY OVERVIEW 422
TABLE 472 HOYA CORPORATION: PRODUCTS OFFERED 423
TABLE 473 HOYA CORPORATION: DEALS, JANUARY 2021–OCTOBER 2025 424
TABLE 474 ESSILORLUXOTTICA: COMPANY OVERVIEW 426
TABLE 475 ESSILORLUXOTTICA: PRODUCTS OFFERED 426
TABLE 476 ESSILORLUXOTTICA: DEALS, JANUARY 2021–OCTOBER 2025 428
TABLE 477 CANON: COMPANY OVERVIEW 429
TABLE 478 CANON: PRODUCTS OFFERED 431
TABLE 479 GLAUKOS CORPORATION: COMPANY OVERVIEW 432
TABLE 480 GLAUKOS CORPORATION: PRODUCTS OFFERED 433
TABLE 481 GLAUKOS CORPORATION: PRODUCT APPROVALS, JANUARY 2021–OCTOBER 2025 434
TABLE 482 GLAUKOS CORPORATION: DEALS, JANUARY 2021–OCTOBER 2025 434
TABLE 483 TOPCON CORPORATION: COMPANY OVERVIEW 435
TABLE 484 TOPCON CORPORATION: PRODUCTS OFFERED 436
TABLE 485 TOPCON CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–OCTOBER 2025 438
TABLE 486 TOPCON CORPORATION: DEALS, JANUARY 2021–OCTOBER 2025 438
TABLE 487 NIDEK CO., LTD.: COMPANY OVERVIEW 439
TABLE 488 NIDEK CO., LTD.: PRODUCTS OFFERED 439
TABLE 489 NIDEK CO., LTD.: PRODUCT LAUNCHES, JANUARY 2021–OCTOBER 2025 442
TABLE 490 NIDEK CO., LTD.: DEALS, JANUARY 2021–OCTOBER 2025 442
TABLE 491 STAAR SURGICAL: COMPANY OVERVIEW 443
TABLE 492 STAAR SURGICAL: PRODUCTS OFFERED 444
TABLE 493 STAAR SURGICAL: PRODUCT APPROVALS, JANUARY 2021–OCTOBER 2025 444
TABLE 494 HALMA PLC: COMPANY OVERVIEW 445
TABLE 495 HALMA PLC: PRODUCTS OFFERED 446
TABLE 496 HAAG-STREIT: COMPANY OVERVIEW 448
TABLE 497 HAAG-STREIT: PRODUCTS OFFERED 448
TABLE 498 HAAG-STREIT: PRODUCT LAUNCHES, JANUARY 2021–OCTOBER 2025 449
TABLE 499 HAAG-STREIT: DEALS, JANUARY 2021–OCTOBER 2025 450
TABLE 500 SHANGHAI MEDIWORKS PRECISION INSTRUMENTS CO., LTD.:
COMPANY OVERVIEW 451
TABLE 501 SHANGHAI MEDIWORKS PRECISION INSTRUMENTS CO., LTD.:
PRODUCTS OFFERED 451
TABLE 502 VISIONIX: COMPANY OVERVIEW 452
TABLE 503 VISIONIX: PRODUCTS OFFERED 452
TABLE 504 VISIONIX: DEALS, JANUARY 2021–JULY 2025 453
TABLE 505 VISUNEX MEDICAL SYSTEMS: COMPANY OVERVIEW 454
TABLE 506 COSTRUZIONE STRUMENTI OFTALMICI: COMPANY OVERVIEW 455
TABLE 507 HAI LABORATORIES, INC.: COMPANY OVERVIEW 456
TABLE 508 FORUS HEALTH: COMPANY OVERVIEW 457
TABLE 509 ZIEMER OPHTHALMIC SYSTEMS AG: COMPANY OVERVIEW 458
TABLE 510 CRYSTALVUE MEDICAL CORPORATION: COMPANY OVERVIEW 459
TABLE 511 REMIDIO INNOVATIVE SOLUTIONS PVT. LTD.: COMPANY OVERVIEW 460
TABLE 512 SUZHOU KANGJIE MEDICAL INC.: COMPANY OVERVIEW 461
TABLE 513 LUMENIS: COMPANY OVERVIEW 462
TABLE 514 OPHTEC BV: COMPANY OVERVIEW 463
LIST OF FIGURES
FIGURE 1 OPHTHALMIC EQUIPMENT MARKET SEGMENTATION & REGIONAL SCOPE 39
FIGURE 2 YEARS CONSIDERED 40
FIGURE 3 RESEARCH DESIGN 45
FIGURE 4 PRIMARY SOURCES 47
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 49
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE PARTICIPANTS 50
FIGURE 7 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS 51
FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: ALCON INC. 51
FIGURE 9 SUPPLY-SIDE MARKET SIZE ESTIMATION: OPHTHALMIC
EQUIPMENT MARKET (2024) 52
FIGURE 10 BOTTOM-UP APPROACH: SURGICAL DEVICES COMPANY
REVENUE ESTIMATION APPROACH 53
FIGURE 11 BOTTOM-UP APPROACH: DIAGNOSTIC & MONITORING
DEVICES COMPANY REVENUE ESTIMATION APPROACH 53
FIGURE 12 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 54
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN OPHTHALMIC EQUIPMENT MARKET (2025–2030): IMPACT ON GROWTH & CAGR 56
FIGURE 14 DATA TRIANGULATION METHODOLOGY 57
FIGURE 15 OPHTHALMIC EQUIPMENT MARKET, BY TECHNOLOGY,
2025 VS. 2030 (USD MILLION) 60
FIGURE 16 OPHTHALMIC EQUIPMENT MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION) 61
FIGURE 17 OPHTHALMIC EQUIPMENT MARKET FOR SURGICAL DEVICES, BY TYPE,
2025 VS. 2030 (USD MILLION) 61
FIGURE 18 OPHTHALMIC EQUIPMENT MARKET FOR DIAGNOSTIC & MONITORING DEVICES,
BY TYPE, 2025 VS. 2030 (USD MILLION) 62
FIGURE 19 OPHTHALMIC EQUIPMENT MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 63
FIGURE 20 REGIONAL SNAPSHOT OF OPHTHALMIC EQUIPMENT MARKET 64
FIGURE 21 RISING PREVALENCE OF EYE DISEASES TO DRIVE MARKET GROWTH 65
FIGURE 22 HOSPITALS DOMINATED NORTH AMERICAN OPHTHALMIC
EQUIPMENT MARKET IN 2024 66
FIGURE 23 INDIA TO REGISTER HIGHEST GROWTH RATE FROM 2025 TO 2030 67
FIGURE 24 NORTH AMERICA TO LEAD MARKET UNTIL 2030 68
FIGURE 25 DEVELOPING MARKETS TO REGISTER FASTER GROWTH DURING
FORECAST PERIOD 68
FIGURE 26 OPHTHALMIC EQUIPMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 69
FIGURE 27 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 79
FIGURE 28 AVERAGE SELLING PRICE TREND OF OPTICAL COHERENCE TOMOGRAPHY SYSTEMS, BY REGION, 2022–2024 81
FIGURE 29 OPHTHALMIC EQUIPMENT MARKET: VALUE CHAIN ANALYSIS 82
FIGURE 30 OPHTHALMIC EQUIPMENT MARKET: SUPPLY CHAIN ANALYSIS 83
FIGURE 31 OPHTHALMIC EQUIPMENT MARKET: ECOSYSTEM ANALYSIS 84
FIGURE 32 OPHTHALMIC EQUIPMENT MARKET: INVESTMENT & FUNDING
SCENARIO, 2019–2023 86
FIGURE 33 OPHTHALMIC EQUIPMENT MARKET: VALUE OF INVESTOR DEALS,
BY KEY PLAYER, 2019–2023 86
FIGURE 34 OPHTHALMIC EQUIPMENT MARKET: NUMBER OF INVESTOR DEALS,
BY KEY PLAYER, 2019–2023 (USD MILLION) 87
FIGURE 35 OPHTHALMIC EQUIPMENT MARKET: PATENT ANALYSIS,
JANUARY 2015−OCTOBER 2025 91
FIGURE 36 OPHTHALMIC EQUIPMENT MARKET: PORTER’S FIVE FORCES ANALYSIS 102
FIGURE 37 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS OF OPHTHALMIC EQUIPMENT PRODUCTS 104
FIGURE 38 KEY BUYING CRITERIA FOR OPHTHALMIC EQUIPMENT PRODUCTS 105
FIGURE 39 OPHTHALMIC EQUIPMENT MARKET: IMPACT OF AI/GEN AI 110
FIGURE 40 OPHTHALMIC EQUIPMENT MARKET: ADJACENT MARKETS 110
FIGURE 41 OPHTHALMIC EQUIPMENT MARKET: REGIONAL GROWTH OPPORTUNITIES 237
FIGURE 42 NORTH AMERICA: OPHTHALMIC EQUIPMENT MARKET SNAPSHOT 238
FIGURE 43 ASIA PACIFIC: OPHTHALMIC EQUIPMENT MARKET SNAPSHOT 297
FIGURE 44 REVENUE ANALYSIS OF TOP PLAYERS IN OPHTHALMIC EQUIPMENT MARKET, 2020–2024 (USD MILLION) 384
FIGURE 45 MARKET SHARE ANALYSIS OF KEY PLAYERS IN OPHTHALMIC EQUIPMENT
MARKET, 2024 385
FIGURE 46 OPHTHALMIC EQUIPMENT MARKET: COMPANY EVALUATION
MATRIX (KEY PLAYERS), 2024 387
FIGURE 47 OPHTHALMIC EQUIPMENT MARKET: COMPANY FOOTPRINT 388
FIGURE 48 OPHTHALMIC EQUIPMENT MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 393
FIGURE 49 EV/EBITDA OF KEY VENDORS 396
FIGURE 50 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK
BETA OF KEY VENDORS 396
FIGURE 51 OPHTHALMIC EQUIPMENT MARKET: BRAND/PRODUCT COMPARISON 397
FIGURE 52 ALCON: COMPANY SNAPSHOT (2024) 405
FIGURE 53 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2024) 410
FIGURE 54 CARL ZEISS MEDITEC AG: COMPANY SNAPSHOT (2024) 414
FIGURE 55 BAUSCH HEALTH COMPANIES INC.: COMPANY SNAPSHOT (2024) 419
FIGURE 56 HOYA CORPORATION: COMPANY SNAPSHOT (2024) 423
FIGURE 57 CANON: COMPANY SNAPSHOT (2024) 430
FIGURE 58 GLAUKOS CORPORATION: COMPANY SNAPSHOT (2024) 433
FIGURE 59 TOPCON CORPORATION: COMPANY SNAPSHOT (2024) 436
FIGURE 60 STAAR SURGICAL: COMPANY SNAPSHOT (2024) 443
FIGURE 61 HALMA PLC: COMPANY SNAPSHOT (2024) 446
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11